Dr. Stephen J. Eyre, MD

Dr. Eyre practices at The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts.

Dr. Eyre's NPI, 1417129826, was assigned on March 25, 2008. Dr. Eyre graduated from Tufts University School Of Medicine in 2008. Dr. Eyre's Massachusetts license number on file is 255388.

Dr. Eyre's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD, at 148 Chestnut St, Needham, MA 02492.

Dr. Eyre's primary practice is The Cancer Center at Beth Israel Deaconess Medical Center - Physical Therapy - HOPD in Needham, Massachusetts. Dr. Eyre is also affiliated with Beth Israel Deaconess Hospital-Needham. The medical group on file is Harvard Medical Faculty Physicians at Beth Israel Deaconess Medical Center. Dmand AI also links Dr. Eyre to 2 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Eyre practices, 5 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Eyre's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Eyre is board certified in urology by the American Board of Urology. Dr. Eyre has a license on file in Massachusetts.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Eyre treats.

CMS data shows 3,532 Medicare services from Dr. Eyre across 22 procedure codes in 2024, for 1,052 Medicare patients. Medicare paid $248,431 for them.

CMS counts 1,052 Medicare patients who saw Dr. Eyre in 2024. The largest group is 75 to 84, with 436 patients. 75% of them have high cholesterol, and 72% have high blood pressure. 6% are also on Medicaid. Their average risk score is 1.10, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Eyre's median patient age at 74, with 14% women.

In 2024, Dr. Eyre wrote 2,033 Medicare Part D claims for 588 patients. 94% of them were for generic drugs. CMS names the drug for 1,912 of them, across 30 drugs with 11 or more claims each, at $129,467 in total drug cost. In 2023, CMS named 1,264 claims across 26 drugs.

Dr. Eyre accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Eyre as offering telehealth.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 46 papers to Dr. Eyre, published from 2005 to 2021. 2016 was the busiest year, with 4. The most frequent topics are Polymorphism, Single Nucleotide, Genetic Predisposition to Disease and Arthritis, Rheumatoid. Dr. Eyre has published most often in Ann Rheum Dis. Dr. Eyre's most frequent co-authors are John Duane Isaacs, MD, Jonathan Scott Coblyn, MD and Lindsey A. Criswell, MD.

CMS Open Payments shows 22 general payments to Dr. Eyre from 6 drug and device companies from 2017 to 2024. Consulting fees make up the largest share, 96% of the total. Boston Scientific Corporation paid the most, $14,969.

Dmand AI lists 1 award for Dr. Eyre, most recently CMS Stage 1 EHR in 2013.

Dr. Eyre graduated from Tufts University School Of Medicine in 2008.

Dr. Eyre is in network with 11 carriers, including Aetna, Excellus BlueCross BlueShield and Elevance. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.